Nuvectis Pharma, Inc. (NVCT)

NASDAQ: NVCT · Real-Time Price · USD

20.24

+0.01 (0.05%)

Nov 13, 2026, 4:00 PM EST - Market closed

Nuvectis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	696	193	105	145	110	-
Market Cap Growth	352.13%	85.02%	-27.66%	31.58%	-	-
Enterprise Value	555	158	87	122	86	-
Last Close Price	20.24	7.55	5.41	8.34	7.50	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	5.50	10.50	10.76	11.84	7.72	-
P/TBV Ratio	5.50	10.50	10.76	11.84	7.72	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Debt / Equity Ratio	-1.11	-1.72	-1.91	-1.57	-1.41	-1.35
Quick Ratio	9.91	2.38	2.08	2.74	3.23	2.37
Current Ratio	9.92	2.38	2.09	2.75	3.30	2.41
Return on Equity (ROE)	-66.98%	-188.03%	-173.41%	-168.51%	-206.81%	-609.74%
Return on Assets (ROA)	-36.93%	-68.50%	-65.64%	-69.14%	-83.30%	-
Return on Capital Employed (ROCE)	-41.20%	-149.80%	-204.30%	-179.50%	-126.80%	-136.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-10.01%	-13.67%	-18.18%	-15.40%	-17.38%	-
Buyback Yield / Dilution	-21.77%	-27.46%	-10.01%	-22.90%	-196.55%	-9.44%

SEC Filings: 10-K · 10-Q